Induction With Intravitreal Bevacizumab Every Two Weeks in the Management of Neovascular Age-Related Macular Degeneration

Jan 7, 2017 by in OPHTHALMOLOGY Comments Off on Induction With Intravitreal Bevacizumab Every Two Weeks in the Management of Neovascular Age-Related Macular Degeneration

Purpose To explore the benefit of rapid induction with intravitreal bevacizumab for neovascular age-related macular degeneration (AMD). Design Single-institution prospective randomized pilot study. Methods Patients with treatment-naïve neovascular AMD were…

read more

Reevaluating the Definition of Intraretinal Microvascular Abnormalities and Neovascularization Elsewhere in Diabetic Retinopathy Using Optical Coherence Tomography and Fluorescein Angiography

Jan 7, 2017 by in OPHTHALMOLOGY Comments Off on Reevaluating the Definition of Intraretinal Microvascular Abnormalities and Neovascularization Elsewhere in Diabetic Retinopathy Using Optical Coherence Tomography and Fluorescein Angiography

Purpose To evaluate the agreement between clinical examination, spectral-domain ocular coherence tomography (SD OCT), and fluorescein angiography (FA) in diagnosing intraretinal microvascular abnormality (IRMA) and neovascularization elsewhere (NVE) and define…

read more

Reproducibility of Retinal Nerve Fiber Layer Thickness Measures Using Eye Tracking in Children With Nonglaucomatous Optic Neuropathy

Jan 7, 2017 by in OPHTHALMOLOGY Comments Off on Reproducibility of Retinal Nerve Fiber Layer Thickness Measures Using Eye Tracking in Children With Nonglaucomatous Optic Neuropathy

Purpose To determine the intra- and intervisit reproducibility of circumpapillary retinal nerve fiber layer (RNFL) thickness measures using eye tracking–assisted spectral-domain optical coherence tomography (SD OCT) in children with nonglaucomatous…

read more

Baseline Choroidal Thickness as a Predictor for Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema

Jan 7, 2017 by in OPHTHALMOLOGY Comments Off on Baseline Choroidal Thickness as a Predictor for Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema

Purpose To determine the association between baseline subfoveal choroidal thickness and short-term response to intravitreal anti–vascular endothelial growth factor (anti-VEGF) therapy in diabetic macular edema (DME). Design Retrospective, consecutive case…

read more
Get Clinical Tree app for offline access